Medication info

Cipoten Injection (Ascorbic Acid)

Prescription medication정맥
Ingredient · strength
Ascorbic Acid›500mg / 1mL
Manufacturer / importer
(주)유한양행
Appearance
A clear colorless or pale yellow injection solution in a brown vial
Packaging
20 mL/vial x 10
Approval status
Active

MFDS item code 201505090 · Notified 2015.07.27

Summary

Main use
Prevention of vitamin C deficiency and treatment of scurvy, and promotion of capillary hemorrhage and bone union
Who receives it
Adults
Adult administration
As ascorbic acid, 50 to 1,000 mg daily, administered subcutaneously, intramuscularly, or intravenously once or in multiple divided doses. Adjust appropriately based on age and symptoms.

Ingredients

Manufacturer
(주)유한양행

Efficacy & effects

Prevention of vitamin C deficiency and treatment of scurvy, and promotion of capillary hemorrhage and bone union

  • Vitamin C deficiency
  • scurvy
  • capillary hemorrhage
  • epistaxis
  • gum bleeding
  • hematuria
  • fractures
  • melasma
  • freckles
  • post-inflammatory pigmentation
  • photodermatitis
View approved original text

This medication is primarily used for the prevention and treatment of vitamin C deficiency, such as scurvy. It also helps in situations where the demand for vitamin C increases, such as in pregnant or breastfeeding women, or in those doing heavy physical labor. Additionally, it is known to be effective for capillary hemorrhage, metabolic disorders due to drug use, promotion of bone formation and healing during fractures, as well as treatment of melasma, freckles, post-inflammatory pigmentation, and photodermatitis. It improves skin health and effectively treats problems related to vitamin C deficiency in various situations, contributing to overall health enhancement.

How it is given

Adult administration

As ascorbic acid, 50 to 1,000 mg daily, administered subcutaneously, intramuscularly, or intravenously once or in multiple divided doses. Adjust appropriately based on age and symptoms.

Precautions

This medication should not be administered to patients with allergies to this drug or any of its components. Patients with oxalate nephropathy, thalassemia, gout, or cystinuria should also avoid using this drug. Special caution is required for patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, as hemolysis may occur with high doses. Patients with renal oxalate stones should not exceed 1 gram daily. Side effects such as nausea, vomiting, diarrhea, abdominal cramps, fatigue, flushing, headache, and insomnia may occur during treatment with this medication. Taking more than 1 gram daily may acidify the urine, increasing the risk of diarrhea or kidney stones. Doses over 600 mg may produce a diuretic effect. Caution is advised as excessive doses may lead to precipitation of oxalate or other substances in the urinary tract. This medication is usually taken orally, but should be administered via injection only in acute situations or when oral intake is not feasible, with a prompt transition to oral administration as soon as possible. Concurrent use with salicylates may impede absorption, so co-administration is not recommended. Usage with aspirin, nicotine, alcohol, certain appetite suppressants, iron preparations, anticonvulsants, oral contraceptives, and some antibiotics may affect the drug's efficacy. High doses may reduce the effectiveness of oral anticoagulants, so caution is necessary. During pregnancy, this medication should only be used when the benefits outweigh the risks, and it is advisable not to exceed 1 gram. During breastfeeding, it is known to be safe for the baby if taken within the recommended daily allowance. It is important to inform the doctor prior to any testing as this medication can affect the results of some carbohydrate tests or hematuria tests. Overdosing may lead to diarrhea or kidney stones, and diuretic effects may also occur; therefore, if symptoms arise, discontinue use immediately and visit a hospital. When administered via injection, there may be temporary pain at the injection site, and care should be taken to avoid nerve areas and not to repeat injections at the same site. The infusion rate should be adjusted slowly during intravenous administration to minimize side effects such as dizziness or phlebitis. This medication should be stored away from direct sunlight in a dry place, and kept out of reach of children. Additionally, it should be stored in its original container to prevent misuse or degradation of quality.

Side effects and when to seek care immediately

Serious side effects

Possible hemolysis in patients with G6PD deficiency

Mild side effects

Nausea, vomiting, diarrhea, abdominal cramps, fatigue, flushing, headache, insomnia, diuretic effect, temporary mild pain at the injection site, fainting, dizziness, phlebitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that prevents light exposure. It is also important to maintain the efficacy of the drug by storing it between 2 to 8 degrees Celsius.

Appearance and packaging

Appearance

A clear colorless or pale yellow injection solution in a brown vial

Package unit

20 mL/vial x 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.